Skip to main content

Table 4 Details of surgery and surgical complications

From: Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases

Details of surgical resections

Peri-operative chemotherapy

Surgery alone

Total cohort

 

n = 56 resections (38 patients)

n = 16 resections (13 patients)

n = 72 resections (51 patients)

Type of resection

   

 Wedge

37

10

47

 Segmental

8

2

10

 Lobectomy

8

4

12

 Pneumonectomy

1

0

1

 Not recorded

2

0

2

Metastases removed

   

 Solitary

16

4

20

 Multiple

38

12

50

 Unknown

2

0

2

Median size (range)

14.5 mm (2–60)

15 mm (4–25)

15 mm (2–60)

Lymph node dissection

   

 Yes

22

5

27

Positive histology

4/22 (18%)

1/5 (20%)

5/27 (19%)

 No

31

10

41

 Unknown

3

1

4

Time from last dose of neoadjuvant treatment to surgery

Median days (range)

  

 Any treatment

48.5 (14–207)

  

 Chemotherapy +

37 (25–85)

  

 VEGF inhibitor

   

Surgical Complications *

3/68 (4%)

5/16 (31%)

8/84 (9%)

 Prolonged air leak

3

0

3

 Haemorrhage**

0

1

1

 CVA

0

1

1

 Cardiac Arrhythmia (fast AF)

0

1

1

 Small bowel ileus or obstruction

0

2

2

  1. Numbers in table refer to number of resections unless otherwise specified.
  2. *Surgical complications were evaluated in all operations performed, hence the bilateral sequential resections being counted as separate events and the total n = 86, not 72.
  3. **The patient was fully anticoagulated.
  4. CRC colorectal cancer, CRT chemoradiation, RT radiotherapy, CEA carcinoembryonic antigen, ULN upper limit of normal, VEGF vascular endothelial growth factor, CVA cerebrovascular Accident, AF atrial Fibrillation.